Kleiburg F, de Geus-Oei LF, Luelmo SAC, Spijkerman R, et al. PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients. Eur J Radiol 2024;181:111774.
PMID: 39442347